Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.15T
Market cap1.15T
Price-Earnings ratio
44.48
Price-Earnings ratio44.48
Dividend yield
0.52%
Dividend yield0.52%
Average volume
3.54M
Average volume3.54M
High today
$1,241.89
High today$1,241.89
Low today
$1,204.16
Low today$1,204.16
Open price
$1,221.10
Open price$1,221.10
Volume
2.60M
Volume2.60M
52 Week high
$1,249.45
52 Week high$1,249.45
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

As of today, Eli Lilly(LLY) shares are valued at $1,216.71. The company's market cap stands at 1.15T, with a P/E ratio of 44.48 and a dividend yield of 0.52%.

During the trading session on 2026-07-08, Eli Lilly(LLY) shares reached a daily high of $1,241.89 and a low of $1,204.16. At a current price of $1,216.71, the stock is +1.0% higher than the low and still -2.0% under the high.

Trading volume for Eli Lilly(LLY) stock has reached 2.6M, versus its average volume of 3.54M.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

The stock's 52-week range extends from a low of $623.78 to a high of $1,249.45.

LLY News

Nasdaq 3h
Is It Too Late to Buy Eli Lilly?

Key Points Eli Lilly's Mounjaro and Zepbound are the leading drugs in the GLP-1 space. The company's GLP-1 success has resulted in a lofty valuation for the s...

Is It Too Late to Buy Eli Lilly?
Investor's Business Daily 4h
This Unlikely Growth Stock Is Breaking Out. It Has Nothing To Do With AI — Yet

Stocks To Watch: 14 Names Test And Tease New Buy Zones 7/08/2026 A barrage of stocks to watch like Eli Lilly and Deere, show promise, alongside reminders to ke...

This Unlikely Growth Stock Is Breaking Out. It Has Nothing To Do With AI — Yet
TipRanks 6h
Eli Lilly Stock Gets a Boost as Eczema Treatment Is Approved in Canada

Eli Lilly’s (LLY) stock is getting a boost on an otherwise down day for markets on news that its drug to treat the skin condition eczema has been approved in Ca...

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

Investing.com 7h
Truist raises Eli Lilly stock price target on incretin strength - Investing.com

...

Truist raises Eli Lilly stock price target on incretin strength - Investing.com
Nasdaq 9h
Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026

Key Points Eli Lilly's new oral obesity drug, Foundayo, removes many of the barriers that have limited GLP-1 adoption, potentially expanding the addressable ma...

Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026
TipRanks 9h
Eli Lilly price target raised to $1,500 from $1,250 at RBC Capital

RBC Capital raised the firm’s price target on Eli Lilly (LLY) to $1,500 from $1,250 and keeps an Outperform rating on the shares in a preview of its Q2 results....

Simply Wall St 10h
Eli Lilly Stock Still Looks Below Fair Value Despite Rich Earnings

Eli Lilly stock has surged over the past few years, and at around US$1,235 per share today, investors face a clear tension between strong price momentum and mix...

Eli Lilly Stock Still Looks Below Fair Value Despite Rich Earnings
Nasdaq 24h
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

Key Points Becton, Dickinson supplies equipment whose demand is soaring due to the rise of GLP-1 medicines. Abbott Laboratories' most important growth driver...

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom
Nasdaq 1d
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend

Key Points Eli Lilly and Intuitive Surgical are top players in their respective corners of the healthcare market. Both companies are highly innovative and boa...

U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
The Wall Street Journal 1d
Health Care Roundup: Market Talk

Yves Herman / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

Health Care Roundup: Market Talk

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.